SOURCE: Down Syndrome Research and Treatment Foundation

Down Syndrome Research and Treatment Foundation

August 18, 2009 23:11 ET

DSRTF Elects New Officers for Board of Directors

PALO ALTO, CA--(Marketwire - August 18, 2009) - The Down Syndrome Research and Treatment Foundation (DSRTF) is proud to announce the election of Vince Randazzo and Steve Lazare to the positions of President/Chair and President-elect/Vice Chair of the Foundation's Board of Directors. Vince succeeds Patricia White (Flatley), M.D. of New Vernon, NJ, as DSRTF's President/Board Chair.

Vince Randazzo, of Charlotte, NC, has served on the DSRTF Board of Directors since 2005. He has a 10 year old son with Down syndrome. In his professional life, Randazzo serves as the Deputy Minority Staff Director for the Committee on Financial Services in the U.S. House of Representatives. Previously, he was a Senior Vice President and the Director of Government Relations for Wachovia Corporation in Charlotte, North Carolina.

"I am grateful for the DSRTF board's confidence in me," Randazzo said. "I am excited about the opportunities that lie ahead, committed to the goals of the organization, and look forward to working with Steve to build on the successes of my predecessors, Pat White Flatley and Patty White."

Steve Lazare, of Pleasantville, NY, has served on the DSRTF Board of Directors since 2006. Stephen Lazare is a partner at the Manhattan law firm of Lazare Potter & Giacovas LLP, where he heads the firm's insurance coverage/litigation group. He is active in the New York State Bar Association, currently serving as Chairman of its Section on Insurance Coverage and is a frequent lecturer and author to the legal community. In 2006, Steve -- along with his wife, Mary, and fellow Board member, Anthony Providenti -- co-founded the DSRTF Romp for Research. He previously served on the board of Child Hope International and other non-profit organizations and was a member of the NDSS New York City Buddy Walk Steering Committee in 2004 and 2005. Steve is the proud father of 3 children including his youngest, Anna (5), who was born with Down syndrome.

"I am honored to serve the Down syndrome community in my new role as DSRTF Vice President," Lazare said. "I am excited by the new opportunities that lie ahead, and committed to working with Vince and the rest of the board to advance DSRTF's mission and goals, and to help improve the lives of those currently living with Down syndrome and future generations."

DSRTF Recognizes Exiting Board Chair, Dr. Patricia White, for her Outstanding Service:

Dr. White served as DSRTF Board President and Chair since 2008, and has been a member of the DSRTF Board of Directors since 2005. During her tenure and with her leadership, DSRTF greatly expanded its outreach and achieved its most significant expansion of DSRTF's Research Grants Program.

"I am grateful for the opportunity to have served as DSRTF's President and Chair of the Board of Directors," said Dr. White, "and I look forward to continuing to serve on the DSRTF Board of Directors and work with Vince and Steve to further advance DSRTF's mission and research strategy. It has also been a privilege to work so closely with DSRTF's dedicated leadership and Scientific Advisory Board in developing an expansion of the Foundation's research grants program which has rapidly led to quite remarkable and unprecedented biomedical research results and advances toward the extremely important goal of creating significant new opportunities for children and adults with Down syndrome."

DSRTF is a nonprofit foundation that envisions a new world in which people with Down syndrome can live independently as adults as well as enjoy full inclusion in academic and social environments. Even though cognitive challenges make it difficult for most people with Down syndrome to live independently as adults, DSRTF believes this independence is possible if the foundation achieves its mission:

     To stimulate biomedical research that will accelerate the development
     of treatments to significantly improve cognition for individuals
     with Down syndrome.

     Treatments that will be developed as a result of DSRTF-funded
     research will help individuals with Down syndrome improve their
     memory, learning and speech, thereby allowing these individuals to
     participate more successfully in school and lead more active,
     independent lives.

To date, DSRTF has become the largest private funding source for Down syndrome cognition research in the United States. Since 2004, DSRTF has generated and awarded over $5.6 million to research institutions like Stanford University Medical School, Johns Hopkins Medical School, University of Arizona and University of California, San Diego School of Medicine. Researchers at these institutions are conducting groundbreaking, evidence-based biomedical research and are leading the charge to develop effective new therapies to help individuals with Down syndrome live independent lives.

Contact Information